1-20 of 48
Li Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DDX3X Mutation Endow R-Loop-Dependent Lymphomagenesis

Jie Xiong, Shu Cheng, Hua-man Cai, Yu-Ran Qiu, Wei Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 5756.
https://doi.org/10.1182/blood-2024-206718
Published: 2024
Journal Articles

Integration of Deep Learning in Baseline PET/CT and Multi-Omics Data for Prognostic Modeling in Diffuse Large B-Cell Lymphoma: The Clinicalpet Lymphplex Model

Yue Wang, Xue Wang, Xinyun Huang, Ying Qian, Rongji Mu, Qing Shi, Di Fu, Hongmei Yi, Bin-Shen Ou-Yang, Zhuo Han Li, Shu Cheng, Wang Li, Ning Wen, Pengpeng Xu, Wei Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6224.
https://doi.org/10.1182/blood-2024-206537
Published: 2024
Journal Articles

Investigating Prognostic Value of Immunoglobulin Next-Generation Sequencing in B Cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy

Yi-Lun Zhang, Lingshuang Sheng, Rong Shen, Wen Wu, Xin Zheng, Li Wang, Shu Cheng, Peng-Peng Xu, Qi-Jie Jian, Bo Peng, Ke Zhang, Fei Pang, Kai Wang, Zi-Xun Yan, Wei-Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6208.
https://doi.org/10.1182/blood-2024-209889
Published: 2024
Journal Articles

Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology

Yuqing Wang, Shuo Wang, Hongmei Yi, Yue Wang, Haimin Xu, Shuang Tian, Yan Dong, Jing Zhao, Di Fu, Rongji Mu, Shuye Wang, Li Wang, Pengpeng Xu, Wei Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 4974.
https://doi.org/10.1182/blood-2024-202864
Published: 2024
Journal Articles

Clonal Origin of Therapy-Related Myeloid Neoplasms after Autologous Stem Cell Transplant

Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Kapadia, Ken Furudate, Jyoti Nangalia, Michael Spencer Chapman, Li Zhao, Joanne Hsu, Chong Zhao, Shujuan Chen, Tomoyuki Tanaka, Zongrui Li, Hui Yang, Courtney D. DiNardo, Naval Daver, Naveen Pemmaraju, Nitin Jain, Farhad Ravandi, Jianhua Zhang, Xingzhi Song, Erika Thompson, Hongli Tang, Latasha Little, Curtis Gumbs, Robert Z. Orlowski, Muzaffar H. Qazilbash, Kapil N. Bhalla, Simona Colla, Hagop M. Kantarjian, Rashmi Kanagal-Shamanna, Carlos E. Bueso-Ramos, Daisuke Nakada, Jeffrey J. Molldrem, Gheath Alatrash, Andrew Futreal, Elizabeth J. Shpall, Margaret Goodell, Guillermo Garcia-Manero, Koichi Takahashi
Journal: Blood
Blood (2024) 144 (Supplement 1): 346.
https://doi.org/10.1182/blood-2024-208106
Published: 2024
Journal Articles

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Lingshuang Sheng, Zixun Yan, Li Wang, Wen Wu, Yilun Zhang, Rong Shen, Weiguo Cao, Lei Li, Sheng Chen, Xufeng Jiang, Hongmei Yi, Qi Song, Li Wang, Shu Cheng, Pengpeng Xu, Xuanming Yang, Yuxiang Zhu, Xikang Xu, Fuzhe Wang, Jianyong Li, Wei Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 4822.
https://doi.org/10.1182/blood-2024-198296
Published: 2024
Journal Articles

Efficacy and Safety of Chidamide Combined with BEAM Conditioning Regimen in Autologous Transplantation for T-Cell Lymphoma

Yige Shen, Zhong Zheng, Mengmeng Ji, Wei Tang, Wei Li Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2023-177562
Published: 2023
Journal Articles

Preliminary Results from a Phase I/II Study of Pomalidomide Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (PRIDE)

Pengpeng Xu, Wang Li, Shu Cheng, Wei Li Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6229.
https://doi.org/10.1182/blood-2023-186087
Published: 2023
Journal Articles

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Emanuele Zucca, Luca Ceriani, Andrew S. Davies, Giovannino Ciccone, Umberto Ricardi, Alice Di Rocco, Iryna Kryachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Vittorio Ruggero Zilioli, Sara Usai, Luca Arcaini, Elsa Pennese, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Franceso Merli, Wei Li Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Stefano Volpetti, Carla Minoia, Michele Spina, Alexander Fossa, George Mikhaeel, Kate Cwynarski, Andrea Janikova, Yana Stepanishyna, Mats Jerkeman, Andreas Huettmann, Maria Gomes da Silva, Don A. Stevens, Sally F Barrington, Bogdan Małkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Oreste Bagni, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Letizia Deantonio, Jan Walewski, Marek Trneny, Mary Gospodarowicz, Franco Cavalli, Peter Johnson, Maurizio Martelli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1718.
https://doi.org/10.1182/blood-2023-174093
Published: 2023
Journal Articles

Iron Restricted Erythropoiesis Under Hepcidin Mimetic Treatment (PN23114) Improved Disease Parameters in a Mouse Model for Sickle Cell Disease

Roopa Taranath, Li Zhao, Gregory Bourne, Ramesh R Bhatt, Scott Plevy, David Y Liu, Ashok Bhandari
Journal: Blood
Blood (2023) 142 (Supplement 1): 1117.
https://doi.org/10.1182/blood-2023-182472
Published: 2023
Journal Articles

Update of Swatch Study: Selinxor Combined with Lenalidomide and Rituximab (R2) in Adults with Diffuse Large B Cell Lymphoma (DLBCL) and Indolent Non-Hodgkin's Lymphoma (iNHL)

Li Wang, Zhiming Li, Lina Zhang, Liling Zhang, Jay Mei, Wei Li Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6235.
https://doi.org/10.1182/blood-2023-180535
Published: 2023
Journal Articles

Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant

Xing-yu Cao, Jian-Ping Zhang, Yan-Li Zhao, Min Xiong, Jiarui Zhou, Yue Lu, Ruijuan Sun, Zhijie Wei, Deyan Liu, Xian Zhang, Junfang Yang, Peihua Lu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4802–4803.
https://doi.org/10.1182/blood-2022-166993
Published: 2022
Journal Articles

Cancer Chemotherapy Accelerates the Loss of Clonal Diversity in Hematopoietic Stem Cells and Promotes the Convergent Evolution of Therapy-Related Clonal Hematopoiesis

Hidetaka Uryu, Koichi Saeki, Jyoti Nangalia, Michael Spencer Chapman, Li Zhao, Joanne I. Hsu, Carlos E. Bueso-Ramos, Shujuan Chen, Hui Yang, Hagop Kantarjian, Courtney D. DiNardo, Naval Daver, Simona Colla, Irene Ganan-Gomez, Jianhua Zhang, Xingzhi Song, Erika Thompson, Hongli Tang, Robert Z. Orlowski, Richard E Champlin, Muzaffar H Qazilbash, Elizabeth J Shpall, Guillermo Garcia-Manero, Hiroshi Haeno, Koichi Takahashi, Andrew Futreal
Journal: Blood
Blood (2022) 140 (Supplement 1): 2232–2233.
https://doi.org/10.1182/blood-2022-160294
Published: 2022
Journal Articles

Regulation of Iron Homeostasis and Efficacy of Rusfertide Analog Peptide in a Mouse Model for Polycythemia Vera

Roopa Taranath, Li Zhao, Jayanthi Vengalam, Lawrence Lee, Tenny Tang, Celino Dion, Ahu Su, James Tovera, Ashok Bhandari, Xiaoli Cheng, Larry Mattheakis, David Y Liu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2006.
https://doi.org/10.1182/blood-2021-154118
Published: 2021
Journal Articles

Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patients

Daobin Zhou, Jie Jin, Zheng-zheng Fu, Shuhua Yi, Wei Li Zhao, Zimin Sun, Wei Yang, Dengju Li, Guohui Cui, Jianda Hu, Ting Liu, Yongping Song, Bing Xu, Zunmin Zhu, Wei Xu, Mingzhi Zhang, Yamin Tian, Huaqiang Zhu, Bin Zhang, Renbin Zhao, Xiang-Yang Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 46.
https://doi.org/10.1182/blood-2021-149350
Published: 2021
Journal Articles

Trial in Progress: Pomalidomide Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (PRIDE)

Pengpeng Xu, Li Wang, Shu Cheng, Wei Li Zhao
Journal: Blood
Blood (2021) 138 (Supplement 1): 4562.
https://doi.org/10.1182/blood-2021-146851
Published: 2021
Journal Articles

Trial in Progress: Real-World Safety and Effectiveness of Brentuximab Vedotin in Adults with CD30+ Lymphoma in China

Pengpeng Xu, Mingci Cai, Wendy Zhang, Wei Li Zhao
Journal: Blood
Blood (2021) 138 (Supplement 1): 4552.
https://doi.org/10.1182/blood-2021-149031
Published: 2021
Journal Articles

Hepcidin Peptidomimetics - Oral Efficacy in Pre-Clinical Disease Model of Iron Overload

Roopa Taranath, PhD, Gregory Bourne, PhD, Jie Zhang, PhD, Brian Frederick, MS, Tran T Tran, PhD, Ashok Bhandari, PhD, Jayanthi Vengalam, MS, Jaimee McMahon, Keith Huie, MS, Grace A Ledet, MS, Li Zhao, MD PhD, James Tovera, Larry Lee, Bo Yang, PhD, Celino Dion, Lucy Yuan, Genet Zemede, MS, Michelle Nguyen, Mohammad Masjedizadeh, PhD, Xiaoli Cheng, PhD, Larry Mattheakis, PhD, David Liu, PhD, Mark L Smythe, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-141720
Published: 2020
Journal Articles

Mechanism of Systemic Iron Regulation and Hematocrit Control By Hepcidin Peptidomimetics in Pre-Clinical Models

Roopa Taranath, PhD, Larry Mattheakis, PhD, Li Zhao, MD PhD, Larry Lee, James Tovera, Jingsong Zhao, PhD, Xiaoli Cheng, PhD, David Liu, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-141670
Published: 2020
Journal Articles

Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib

Yuya Sasaki, MDPhD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Latasha Little, BS, Curtis Gumbs, Li Zhao, PhD, P Andrew Futreal, PhD, Feng Wang, PhD, Ken Furudate, DDM, PhD, Rebecca Garris, MSc, Koichi Takahashi, MD PhD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-136676
Published: 2020